Cargando…

Myocardial adaptation after surgical therapy differs for aortic valve stenosis and hypertrophic obstructive cardiomyopathy

Surgical therapies in aortic valve stenosis (AVS) and hypertrophic obstructive cardiomyopathy (HOCM) aim to relief intraventricular pressure overload and improve clinical outcome. It is currently unknown to what extent myocardial adaptation concurs with restoration of intraventricular pressures, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parbhudayal, Rahana Y., Güçlü, Ahmet, Zweerink, Alwin, Biesbroek, P. Stefan, Croisille, Pierre, Clarysse, Patrick, Michels, Michelle, Stooker, Wim, Vonk, Alexander B. A., van der Ven, Peter M., van Rossum, Albert C., van der Velden, Jolanda, Nijveldt, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534665/ https://www.ncbi.nlm.nih.gov/pubmed/30825136 http://dx.doi.org/10.1007/s10554-019-01563-3

Ejemplares similares

Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
por: Parbhudayal, Rahana Y., et al.
Publicado: (2021)

Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic TNNT2 Gene Variants
por: Parbhudayal, Rahana Y., et al.
Publicado: (2020)

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Strain analysis in CRT candidates using the novel segment length in cine (SLICE) post-processing technique on standard CMR cine images
por: Zweerink, Alwin, et al.
Publicado: (2017)

Scientists on the spot: Relaxing the heart in hypertrophic cardiomyopathy
por: Gladka, Monika M, et al.
Publicado: (2023)

ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study)
por: Güçlü, A., et al.
Publicado: (2013)

The effect of inhibition of the Na(+)/H(+) exchanger on the development of hypertrophy in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2011)

Metabolomics in Severe Aortic Stenosis Reveals Intermediates of Nitric Oxide Synthesis as Most Distinctive Markers
por: van Driel, Beau Olivier, et al.
Publicado: (2021)

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
por: Rüssel, Iris K, et al.
Publicado: (2011)

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2014)

Life-long tailoring of management for patients with hypertrophic cardiomyopathy: Awareness and decision-making in changing scenarios
por: Michels, M., et al.
Publicado: (2016)

Comparison of strain imaging techniques in CRT candidates: CMR tagging, CMR feature tracking and speckle tracking echocardiography
por: van Everdingen, Wouter M., et al.
Publicado: (2017)

Strain imaging to predict response to cardiac resynchronization therapy: a systematic comparison of strain parameters using multiple imaging techniques
por: Zweerink, Alwin, et al.
Publicado: (2018)

Blood‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis
por: Jansen, Mark, et al.
Publicado: (2022)

Five-year prognostic significance of global longitudinal strain in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes
por: van Velzen, H. G., et al.
Publicado: (2019)

Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy
por: Dorsch, Larissa M., et al.
Publicado: (2019)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
por: Becker, Marthe A.J., et al.
Publicado: (2020)

How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance
por: Germans, Tjeerd, et al.
Publicado: (2010)

Sex-specific cardiac remodeling in early and advanced stages of hypertrophic cardiomyopathy
por: Nijenkamp, Louise L. A. M., et al.
Publicado: (2020)

Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Don’t judge the myocardium by its cover: The incremental value of cardiac magnetic resonance imaging in left ventricular hypertrophy
por: Parbhudayal, R. Y., et al.
Publicado: (2017)

Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier
por: Nollet, Edgar E., et al.
Publicado: (2020)

Global circumferential left ventricular strain impairment in hypertrophic cardiomyopathy: comparison to left ventricular hypertrophy and late gadolinium enhancement
por: Macron, Laurent, et al.
Publicado: (2013)

Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration
por: Nollet, Edgar E, et al.
Publicado: (2023)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

FHL2 expression and variants in hypertrophic cardiomyopathy
por: Friedrich, Felix W., et al.
Publicado: (2014)

Translational investigation of electrophysiology in hypertrophic cardiomyopathy
por: Flenner, Frederik, et al.
Publicado: (2021)

MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy
por: McNamara, James W., et al.
Publicado: (2017)

Extra energy for hearts with a genetic defect: ENERGY trial
por: van Driel, B. O., et al.
Publicado: (2019)

Correction to: Extra energy for hearts with a genetic defect: ENERGY trial
por: van Driel, B. O., et al.
Publicado: (2019)

Diastolic myofilament dysfunction in the failing human heart
por: van der Velden, Jolanda
Publicado: (2011)

Individual, societal and clinical burden of cardiovascular disease: health technology assessment to guide new diagnostics and treatment strategies
por: van der Velden, Jolanda
Publicado: (2023)

A systematic literature review of economic evaluations and cost-of-illness studies of inherited cardiomyopathies
por: Wiethoff, Isabell, et al.
Publicado: (2023)

Effect of body surface area and gender on wall thickness thresholds in hypertrophic cardiomyopathy
por: Huurman, R., et al.
Publicado: (2019)

Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Segment length in cine (SLICE) strain analysis: a practical approach to estimate potential benefit from cardiac resynchronization therapy
por: Zweerink, Alwin, et al.
Publicado: (2021)

Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance( )
por: Huurman, Roy, et al.
Publicado: (2022)

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants
por: Jansen, Mark, et al.
Publicado: (2023)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Simulation based evaluation of cardiac motion estimation methods in tagged-MR Image sequences
por: Clarysse, Patrick, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ufvnkqar5gmlgnqod2rc863jmr